Why the study?
Does intravenous thrombolysis safely treat embolic stroke due to cardiac myxoma without causing intracranial hemorrhage?
Does intravenous thrombolysis safely treat embolic stroke due to cardiac myxoma without causing intracranial hemorrhage?
This case report suggests that intravenous thrombolysis may be safely administered for embolic stroke caused by cardiac myxoma without inducing intracranial hemorrhage.
Case report suggests possible thrombolysis safety in myxoma stroke; leaves open prospective validation before practice change.
Cardiac myxoma is a rare but curable cause of ischemic stroke. Current guidelines do not address the use of intravenous thrombolysis for embolic stroke caused by cardiac myxoma. The risk of hemorrhage due to occult tumor emboli or microaneurysms is a major concern. We describe a 45-year-old man who had an embolic stroke in the left middle cerebral artery. The initial National Institutes of Health Stroke Scale (NIHSS) score was 16. He received intravenous thrombolysis 2 h and 52 min after stroke onset. No intracranial hemorrhage developed. A cardiac mass was found in the left atrium and removed surgically 84 h after stroke. Pathological study showed a myxoma with extensive hemorrhage and thrombus over the surface. At the 3-month follow-up, the NIHSS score was 9 and the modified Rankin scale score was 3. Our experience with this patient supports the hypothesis that intravenous thrombolysis may be safely used in the treatment of embolic stroke due to cardiac myxoma.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: